Research reveals the gut microbiota-brain axis as a critical link in understanding and treating neurological disorders through microbial interventions.
Gilead dishes out $66M for San Diego biotech’s ‘tentacles’ in cancer, inflammation
Gilead will pony up $66 million in an upfront payment and equity investment to collaborate with Tentarix Biotherapeutics on biologics for inflammatory diseases and oncology,